The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...

Mississippi Baptist Medical Center teamed up with Genentech to bring awareness of healthy lungs for Lung Cancer Awareness Month. An exhibit of inflatable lungs was set up Wednesday in the hospital ...

1:09 PM ESTHealth Care Longtime Genentech, Roche dealmaker James Sabry to retire Longtime Genentech, Roche dealmaker James Sabry to retire ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group ... respiratory tract infections including infections of the lungs, cold symptoms, and pain or swelling of the nose or throat viral ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Genentech has secured a second marketed stroke therapy after the US Food and Drug Administration (FDA) approved a label expansion for clot-dissolving agent TNKase (tenecteplase) – the first ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a ...